Why Peptides Get Injected — and How the Pill Finally Happened
Why are peptide drugs like semaglutide injected, not swallowed? A clear guide to gut absorption, drug half-life, and how oral GLP-1 pills finally cracked it.
The gut is hostile to peptides, and the body clears them fast. Two unglamorous problems — absorption and half-life — explain nearly everything about how these drugs are dosed.
If you have wondered why peptides are injected rather than swallowed like most pills, the answer sits in the digestive system. Swallow a peptide, and your gut treats it exactly like the protein in a chicken breast: it breaks the chain apart before the molecule can reach the bloodstream and do its job. That single fact shapes how semaglutide, tirzepatide, and their relatives are delivered.
Problem one: the hostile gut
Peptides are fragile by design. The body’s enzymes exist to dismantle them because peptides and proteins are food. A peptide drug taken as an ordinary pill would be digested into useless fragments. So for most of the history of peptide medicine, the only reliable route was to bypass the gut with a needle — an injection under the skin, where the drug enters circulation intact.
That is why the GLP-1 blockbusters started as injections. It was not a marketing choice or an oversight; it was chemistry.
Two ways around the gut
The oral dream persisted, and by 2025 and 2026, two different solutions had arrived.
The first keeps the peptide and smuggles it through. Oral semaglutide pairs the drug with an absorption enhancer that helps a small fraction cross the stomach lining. It works — but only on an empty stomach, with a small sip of water, followed by a wait, and only a modest portion of the dose actually gets absorbed. The peptide survives; the ritual is the price.
The second solution abandons the peptide entirely. Orforglipron activates the same GLP-1 receptor while being a small molecule — a compact, sturdy compound that shrugs off digestion. No fasting, no timing, take it anytime. That chemical difference is precisely why it became the first anytime oral GLP-1. It also flags a subtle point: a GLP-1 drug need not be a peptide at all.
Problem two: the fast clearance
The second unglamorous problem is half-life — how long a drug lasts before the body clears it. Natural GLP-1 vanishes within minutes, which is fine for a passing meal signal and hopeless for a medicine you take once a week.
Drugmakers solved this by engineering persistence. Attach a fatty acid chain to the peptide, and it clings to albumin, a protein abundant in blood, dramatically slowing clearance. That trick stretches a molecule’s working life from minutes to days, turning a fleeting hormone into a once-weekly injection.
The race now is to push half-life further still. Monthly dosing is the next target, and it is exactly the technology behind Metsera, the platform Pfizer paid up to $10 billion to acquire. Longer-acting drugs mean fewer injections, and fewer injections mean more patients who stay on treatment instead of quitting.
Why do these two problems explain so much
Absorption and half-life are the hidden levers behind most peptide-drug news. Whether a drug is a shot or a pill comes down to how it survives the gut. Whether it is dosed daily, weekly, or monthly comes down to how long it lasts in the blood. Most of the innovation in this field — the fatty-acid tails, the absorption enhancers, the pivot to small molecules — is quietly about solving one or both.
The bottom line
Peptides get injected because the gut destroys them and the body clears them quickly. The oral pills that finally arrived did so either by protecting the peptide (oral semaglutide) or by replacing it with a harder-to-digest small molecule (orforglipron). And the push toward monthly dosing is a bet on half-life — the same engineering problem, taken one step further. Grasp those two ideas, and the dosing schedule of nearly any peptide drug stops being a mystery.
Frequently asked questions
Why is semaglutide injected instead of swallowed? Semaglutide is a peptide, and the digestive system breaks peptides apart before they can be absorbed. An injection delivers the drug into the bloodstream intact, bypassing the gut entirely.
Can you get a GLP-1 drug as a pill now? Yes. Oral semaglutide (a peptide, taken on an empty stomach) and orforglipron (a small molecule, taken anytime) are both approved oral options. They solve the gut problem in two different ways.
What does drug half-life mean? Half-life is how long it takes the body to clear half of a drug. A longer half-life means less frequent dosing. Engineering GLP-1 drugs to last about a week is what made once-weekly injections possible; the next target is monthly.
Sources
- Muttenthaler, M., et al. “Trends in peptide drug discovery.” Nature Reviews Drug Discovery, 2021 (peptide delivery and half-life engineering).
- U.S. Food and Drug Administration — prescribing information for oral semaglutide and orforglipron.
- Knudsen, L.B., and Lau, J. — on the design of long-acting GLP-1 analogs and albumin binding, Frontiers in Endocrinology.
- BioPharma Dive — coverage of Metsera’s half-life-extension platform and Pfizer acquisition, 2025.